Detalles de la búsqueda
1.
Prognostic impact of histological discordance between transurethral resection and radical cystectomy.
BJU Int
; 2024 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38344879
2.
Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort.
Jpn J Clin Oncol
; 53(10): 984-990, 2023 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37496400
3.
Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS-JAPAN study.
Int J Clin Oncol
; 28(2): 299-305, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36472710
4.
C-reactive protein as a prognostic predictor for non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guérin therapy: A Japan Urological Oncology Group study analysis.
Int J Urol
; 30(3): 299-307, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36448522
5.
Differential prognostic impact of complete blood count-related parameters by prior use of novel androgen receptor pathway inhibitors in docetaxel-treated castration-resistant prostate cancer patients.
Anticancer Drugs
; 33(1): e541-e547, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34387597
6.
Predictive factors of survival outcomes in first-line therapy for metastatic castration-resistant prostate cancer.
Int J Urol
; 29(1): 26-32, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34549837
7.
Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate Cancer.
Cancer Invest
; 39(3): 251-256, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33393849
8.
Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN.
World J Urol
; 39(7): 2491-2497, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33079252
9.
Prognostic impact of prior local therapy in castration-resistant prostate cancer.
Jpn J Clin Oncol
; 51(7): 1142-1148, 2021 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33621330
10.
Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy.
Int J Clin Oncol
; 26(11): 2104-2112, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34313904
11.
Effect of Smoking on Oncological Outcome among Prostate Cancer Patients after Radical Prostatectomy with Neoadjuvant Hormonal Therapy.
Cancer Invest
; 38(10): 559-564, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33016145
12.
The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study.
Int J Clin Oncol
; 25(12): 2107-2114, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32770439
13.
Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan.
Int J Clin Oncol
; 25(6): 1163-1169, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32125546
14.
Smoking effect on oncological outcome among men with prostate cancer after radical prostatectomy.
Jpn J Clin Oncol
; 47(5): 453-457, 2017 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28184442
15.
Correction to: The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study.
Int J Clin Oncol
; 27(4): 827, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35237924
16.
Co-introduction of a steroid with docetaxel chemotherapy for metastatic castration-resistant prostate cancer affects PSA flare.
BJU Int
; 118(6): 880-884, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26991851
17.
Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer.
Prostate Int
; 10(1): 50-55, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35510101
18.
Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with castration-resistant prostate cancer.
Prostate Int
; 10(1): 7-13, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35229000
19.
Anticancer Effect of Second-line Treatment for Castration-Resistant Prostate Cancer Following First-line Treatment with Androgen Receptor Pathway Inhibitors.
JMA J
; 5(1): 83-90, 2022 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35224264
20.
Prognostic Value of Lower Tract Urinary Symptoms in Clinically Regional Lymph Node-positive Prostate Cancer.
Anticancer Res
; 41(11): 5593-5598, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34732430